Top Markets
Coin of the day
Lakewood-Amedex Biotherapeutics Inc. Common Stock Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT
Rank in Stocks #35448
This biopharmaceutical company is dedicated to developing innovative... This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida.
Share Price
$2.23
Last synced: 2026-08-14
Market Cap
$3.90M
Change (1 day)
-4.48%
Change (1 year)
-
Country
US
Trade Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT)

Category

Number of shares outstanding for Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT)
Number of shares outstanding as of August 2026: 0
According to Lakewood-Amedex Biotherapeutics Inc. Common Stock latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE